Expression studies have consistently identified tumor protein D52 (TPD52) overexpression in tumor cells. Murine TPD52 (mD52) shares 86% identity with the human orthologue. To study a possible role for TPD52 in transformation, 3T3 fibroblasts were transfected with the full-length cDNA for mD52. Expression of mD52 was confirmed by reverse transcription-PCR (RT-PCR), real-time PCR, and Western blot analysis compared with 3T3 and vector-transfected 3T3 (3T3.V), and the resultant cell line was designated 3T3.mD52. At 4 weeks, 3T3.mD52 gained a 2-fold increase in growth rate, lost contact inhibition, and exhibited a marked phenotype change. Further characterization revealed an acquired ability for anchorage-independent cell growth. To determine whether 3T3.mD52 had become tumorigenic, naïve, healthy, immunocompetent syngeneic mice were inoculated subcutaneously with varying cell doses. Tumors measuring >1 cm 2 were detected 60 days postinoculation with 3T3.mD52, and a 50% subcutaneous tumor incidence was obtained with as few as 5 Â 10 5 3T3.mD52 cells. Remarkably, when lungs from 3T3.mD52 tumor-bearing mice were analyzed, numerous tumor nodules were observed, ranging from nodules less than 10 to nodules too numerous to count (inoculation with 1 Â 10 5 and 5 Â 10 6 cells, respectively). Further support for the metastatic capacity of 3T3.mD52 was the demonstration that transforming growth factor (TGF)-BR1 (receptor) expression decreased and TGF-B1 secretion increased in 3T3.mD52 compared with 3T3 controls. cDNA microarray analysis showed a gene expression pattern that further supported mD52-induced transformation and metastasis. Together, these data suggest that mD52 expression in 3T3 cells initiated cellular transformation, tumorigenesis, and progression to metastasis. (Mol Cancer Res 2007;5(2):133 -44) 
Introduction
The human TPD52 gene family (1) is comprised of four genes, hD52 or PrLZ (2, 3), hD53 (1, 4), hD54 (5, 6), hD55 (7). The first D52-like gene to be identified, human TPD52(hD52), was found to be overexpressed in f40% of breast carcinomas (2) . Subsequent reports have shown that hD52 is overexpressed in cancers of the lung (8, 9) , prostate (3, 10, 11) , colon (12) , and ovary (13) , as well as in B cell malignancies (14) . The hD52 gene has been localized to human chromosome 8q21 (2) , a region frequently gained in breast and prostate carcinomas (15) (16) (17) (18) . It has been reported that hD52 represents a target for gene amplification in human breast cancer (19) , where hD52 was the first chromosome 8q21 target gene proposed in any cancer type. Additional studies suggest that hD52 and hD53 genes encode markers or regulators of cancer cell proliferation (1) , suggesting that tumor protein D52 (TPD52) may be important for initiating and perhaps maintaining a tumorigenic and metastatic phenotype. Interestingly, Scanlan et al. (20) identified hD52 as a breast cancer antigen by screening a library of expressed genes from breast cancers with sera from breast cancer patients, demonstrating that hD52 is capable of inducing immunoglobulin G (IgG) antibodies. This suggests a lack of normal immunologic tolerance to hD52, and that hD52 may be sufficiently immunogenic to be explored as an anticancer vaccine.
The D52-like family members encode hydrophilic polypeptides containing between 180 and 200 amino acid residues that include a coiled-coil motif (1, 6) . The coiled-coil motif is required for multimer formation and heterologous interaction with other proteins (5, (21) (22) (23) . A murine orthologue of TPD52 (mD52) has been cloned and, based on the sequence information, is predicted to be 86% identical to TPD52 (1) .
In the present study, we sought to further explore the role of murine TPD52 (mD52) in cell proliferation, and whether mD52 may be involved in the transformation of nonmalignant cells. To this end, we stably expressed the full-length complementary DNA (cDNA) of mD52 in an early version of nontransformed, contact-inhibited 3T3 fibroblasts (24) . Transfection of 3T3 cells with mD52 resulted in increased proliferation, anchorageindependent cell growth, and the ability to form subcutaneous tumors and spontaneous lethal lung metastases in vivo when inoculated into naïve, syngeneic, immunocompetent mice.
Results

Expression of mD52 in Transfected 3T3 Cells
To generate a cell line with elevated expression of mD52 protein, Swiss albino 3T3 cells were transfected with pcDNA.mD52 plasmid containing the full-length cDNA for mD52. The resultant cell line was designated 3T3.mD52. Parental 3T3 cells (24) were simultaneously transfected with pcDNA3.1 plasmid to serve as an empty vector control and designated 3T3.V. Forty-eight hours after transfection, 3T3.V and 3T3.mD52 were selected with G418 at increasing concentrations over time until reaching a concentration of 1 mg/mL. Expression of mD52 mRNA was confirmed by reverse transcription-PCR (RT-PCR) using methods our laboratory previously published (25, 26) . Expression of mD52 was not detected in either the untransfected parental 3T3 cell line or the empty vector control, 3T3.V (Fig. 1A) . However, 3T3.mD52 cells expressed mD52 message detectable by RT-PCR (Fig. 1A) . Protein expression of mD52 was confirmed by Western blot analysis using an anti-mD52 antibody. A band of f27 kDa was observed for the 3T3.mD52 cell line (Fig. 1B) . Examination of the 3T3.V empty vector control cell line revealed no detectable levels of mD52 protein expression by Western blot analysis (Fig. 1B) .
To further evaluate the expression of mD52 by 3T3.mD52 cells, real-time RT-PCR was done Fig. 2A . Consistent with endpoint RT-PCR results, only 3T3.mD52 expressed mD52 at detectable levels at 30 cycles of amplification. The DRn for mD52 expression in 3T3.mD52 at 30 cycles of amplification was >3, compared with nearly 0 for both 3T3 and 3T3.V ( Fig. 2A) . Similarly, the DRn for mD52 expression in 3T3.mD52 was f5 by 33 cycles, whereas the DRn for mD52 expression in both 3T3 and 3T3.V was <1 ( Fig. 2A) . Of note is the observation that the mD52 cDNA amplification curves for 3T3 and 3T3.V were not significantly different, and that the DRn for mD52 expression in 3T3.mD52 at 31 cycles of amplification (see Fig. 2A , arrow) was 7-fold higher than either 3T3 or 3T3.V at the same time point relative to the respective DRn for GAPDH expression for the respective cell line at 31 cycles ( Fig. 2A, inset) . The difference in the amplification curves for real-time RT-PCR and the lack of detection of mD52 protein in 3T3 and 3T3.V show a significant increase in mD52 expression in 3T3.mD52 compared with 3T3 and 3T3.V cells.
mD52 Expression -Induced Transformation of 3T3 Cells
Next, we evaluated whether expression of mD52 protein affected the growth kinetics and morphology of 3T3 cells in vitro. 3T3.mD52 grown in complete medium was compared with 3T3 and 3T3.V by plating 5 Â 10 5 cells in 2 mL of complete medium in duplicate wells of a six-well plate, followed by incubation at 37jC for 48 h. Figure 3A represents standard phase contrast micrographs of each cell line. Both 3T3 and 3T3.V exhibited the characteristic broad, flat fibroblast appearance of 3T3 cells, whereas 3T3.mD52 cells exhibited a smaller, rounded morphology typical of rapidly dividing cells (Fig. 3A) . Growth kinetics over time was evaluated using a standard, commercially available 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Fig. 3B) . By 48 h, 3T3.mD52 showed increased cell proliferation. The growth rate for 3T3.mD52 after 48 and 72 h was significantly greater (P < 0.001) than the growth rates for either 3T3 or 3T3.V (Fig. 3B) .
To further assess whether mD52 expression resulted in the transformation of 3T3 cells, we tested the ability of the three cell lines to form foci in soft agar, demonstrating the capacity for anchorage-independent growth and indication of transformation. As expected from the morphology and proliferation data and previously published information (24) , neither 3T3 nor 3T3.V were capable of forming colonies in soft agar (Fig. 4A) . Strikingly, 3T3.mD52 consistently formed large foci in soft agar visible after 7 to 10 days of culture. 3T3.mD52 had formed >150 (mean of three determinations) large colony foci in 10 microscopic fields compared with less than 10 (mean of three determinations) small clusters of cells for 3T3 and 3T3.V (Fig. 4B) . When cultured beyond 10 days, there was no change in 3T3 and 3T3.V, whereas 3T3.mD52 colonies became easily visible to the naked eye. These data indicate that mD52 expression in 3T3 cells confers the ability to grow in an anchorage-independent fashion in soft agar. Western blot analysis of murine tumor cell lysates generated from 1 Â 10 8 cell equivalents demonstrating mD52 protein expression using a rabbit polyclonal antibody with specificity for mD52 (f27 kDa). 3T3.V served as a negative control. Actin (f43 kDa) served as a control for protein loading. To determine whether anchorage-independent growth observed for bulk cultures of 3T3.mD52 represented a stable phenotype, individual single cell clones of both 3T3.mD52 and 3T3.V were tested for the ability to form foci in soft agar. Consistent with the results for the bulk parental cell lines, no single cell clones of 3T3.V were capable of anchorageindependent growth, whereas individual single cell clones of 3T3.mD52 formed foci that ranged from 130 to 190 large colony foci in 10 microscopic fields (mean of three determinations; Fig. 4C ). When cultured beyond 10 days, there was no change in any 3T3.V clone observed. Similar to what was observed for bulk cultures of 3T3.mD52, colonies of 3T3.mD52 clones became easily visible to the naked eye (data not shown). These data suggest that the transformed phenotype for 3T3.mD52, as assessed by growth in soft agar, is stable.
In vivo Growth and Spontaneous Metastasis of 3T3.mD52 Cells
To determine whether 3T3.mD52 cells were capable of in vivo growth indicative of tumorigenesis, we inoculated syngeneic, naïve, immunocompetent mice subcutaneously, with 5 Â 10 6 viable 3T3.mD52 cells. Within 37 days of inoculation with 3T3.mD52 cells, 100% of mice (n = 5) had a palpable subcutaneous tumor, and by day 60, all tumors had grown near or beyond 1000 mm 3 (Fig. 5A) . In repeat experiments, a total of 20 mice were inoculated subcutaneously with 5 Â 10 6 viable 3T3.mD52 cells, and tumors grew with similar kinetics in all 20 animals. Surprisingly, 3T3.mD52 tumor-bearing mice also had lung metastases (Fig. 5B) . Figure 5B (a and b) shows representative lungs taken from two individual immunocompetent, syngeneic mice that were bearing tumors 60 days following subcutaneous inoculation with 5 Â 10 6 3T3.mD52 cells. These lungs bore visible lung tumor metastases unlike lungs from uninoculated control animals [ Fig. 5B (c) ].
In light of these results, we were interested in determining a minimal tumorigenic inoculum for 3T3.mD52 cells in syngeneic, immunocompetent mice. Groups of mice were injected subcutaneously with varying numbers of viable 3T3.mD52 cells, ranging from 1 Â 10 6 to 1 Â 10 5 cells (Fig. 5C ). Measurable subcutaneous tumors grew in mice from all the dose groups. Figure 5A (inset) represents a day 39 curve of tumor growth for an inoculum of 5 Â 10 6 3T3.mD52 cells, with the X-and Y-axes adjusted for direct comparison to tumor growth curves in Fig. 5C . Strikingly, even the lowest subcutaneous inoculation dose (1 Â 10 5 cells) resulted in the generation of spontaneous lung metastases in 25% of animals (n = 4) bearing subcutaneous tumors (Fig. 5D ). These data suggest that the 50% tumorigenic dose is between 5 Â 10 5 and 1 Â 10 6 3T3.mD52 cells, and a minimal 100% tumorigenic dose is f1 Â 10 6 3T3.mD52 cells. Moreover, these data show that even relatively low-dose subcutaneous inoculation with 3T3.mD52 cells results in spontaneous lung metastases in tumor-bearing animals. To determine whether the in vivo growth ability observed for bulk cultures of 3T3.mD52 represented a stable phenotype, we inoculated syngeneic, naïve, immunocompetent mice subcutaneously with 5 Â 10 6 viable independent single cell clones of 3T3.mD52 cells. Inoculation of mice with 5 Â 10 6 viable independent single cell clones of 3T3.V served as controls. As expected, none of the single cell clones of 3T3.V were capable of subcutaneous growth (Fig. 6D) . Interestingly, subcutaneous inoculation of mice with clones of 3T3.mD52 resulted in variable growth patterns that could be divided into three groups: 3T3.mD52 clones that formed progressively growing subcutaneous tumors similar to the bulk 3T3.mD52 cell line (Fig. 6A) ; 3T3.mD52 clones that formed palpable subcutaneous tumors early that spontaneously regressed over time (Fig. 6B) ; and 3T3.mD52 clones that failed to form detectable subcutaneous tumors (Fig. 6C) . Of note, all 3T3.mD52 clones capable of forming progressively growing subcutaneous tumors also formed spontaneous lung metastases (data not shown) similar to what was observed for the bulk 3T3.mD52 cell line (Fig. 5B ). These data suggest that the bulk 3T3.mD52 cell line comprised clones that are aggressively tumorigenic, less tumorigenic, and nontumorigenic.
Induction of TGF-b1 Expression and Secretion in 3T3.mD52 Cells
It is widely accepted that the family of transforming growth factors (TGF), particularly TGF-h1, plays a role in tumorigenesis, metastasis, and immune suppression (27) . Immune suppression enables the nascent tumor to escape immune surveillance and subsequent destruction. TGF-h1 is also involved in antiproliferative mechanisms within normal cells where TGF-h1 secreted by a cell binds to its own TGF-h1 receptor and inhibits cell growth in an autocrine manner (28) . Expression of both TGF-h1 and TGF-hR1/ALK-5 by 3T3, 3T3.V, and 3T3.mD52 cells was determined by RT-PCR using commercially available primer sets and PCR conditions. Following 35 cycles of RT-PCR amplification, only cDNA from 3T3.mD52 cells produced a detectable TGF-h1 product. TGF-h1 transcripts were not detected in either 3T3 or 3T3.V cells using these PCR conditions and reagents (Fig. 7A, top) . Conversely, TGF-hR1/ALK-5 transcript levels were reduced in 3T3.mD52 cells compared with both 3T3 and 3T3.V, which showed similar TGF-hR1 levels (Fig. 7A, middle) . Flow cytometry analysis of surface expression of TGF-hR1/ALK-5 protein supported these RT-PCR data (data not shown). To analyze TGF-h1 protein expression and secretion by 3T3.mD52 cells, we did a standard antigen capture ELISA with supernatants from cultured 3T3, 3T3.V, and 3T3.mD52 cells. The amount of secreted TGF-h1 produced by 3T3.mD52 was significantly greater (P < 0.001) than either 3T3 or 3T3.V cells at multiple supernatant dilutions (Fig. 7B ). This equated to 3T3.mD52 secreting TGF-h1 concentrations of 1,300 pg/mL/ 24 h and 600 pg/mL/24 h for 1:2 and 1:4 dilutions of the was measured at 24-, 48-, and 72-h intervals using a nonradioactive cell proliferation assay (Promega). Statistical analysis at 48 and 72 h showed a significant difference in proliferation rate between 3T3.mD52 and either 3T3 or 3T3.V. *, P < 0.001. Columns, mean of triplicate determinations at three time points; bars, SE.
supernatant, respectively (Fig. 7C) . The concentration of TGFh1 secreted by 3T3 cells was similar to that of 3T3.V cells, and both secreted significantly lower (P < 0.001) TGF-h1 concentrations than 3T3.mD52 (Fig. 7C ). These data show that expression of mD52 in 3T3 cells produced increased TGFh1 expression and secretion and reduced TGF-h1 receptor expression.
Analysis of Differential Gene Expression in 3T3.mD52 versus 3T3 Cells
It is unlikely that TGF-h1 alone produced the malignant phenotype and gain of metastatic ability observed in 3T3.mD52 cells. To determine other gene expression changes in 3T3.mD52 cells, we did cDNA microarray analysis. Differential gene expression was assessed by comparing gene expression in 3T3 and 3T3.mD52 cells using the Affymetrix (Santa Clara, CA) GeneChip Mouse Genome 430 2.0 Array, containing over 39,000 transcripts. In addition to a 24-fold increase in mD52 expression, several genes involved in cancer progression and metastasis showed increased expression in 3T3.mD52 cells (Table 1) . Up-regulated genes include the oncogenes Vav3 (29), Myc, and homologue U of Ras, as well as adhesion molecules integrin-a3, integrin-a6 (30) (31) (32) , and lamanin-a5 (Lama5; ref. 33). 3T3.mD52 cells also showed 16-and 12-fold increased expression of cathepsin H and cathepsin C, respectively (Table 1 ). In addition, the expression of several putative tumor suppressor genes was significantly down-regulated. For example, the expression of cadherin 2, cadherin 11, and protocadherins 7 and 18 showed 155-, 122-, 124-and 8-fold decreases in expression, respectively (Table 1) . A 10-fold decrease in expression of caveolin was also observed in 3T3.mD52 cells. Decreased expression of caveolin has been reported as correlating with cancer progression (34) . Tumorinduced generation of new blood vessels or angiogenesis is a critical step in tumor progression and metastasis. Thrombospondin-2 , implicated in preventing angiogenesis (35) , showed a 39-fold decrease in expression in 3T3.mD52 cells compared with 3T3 cells (Table 1) . Numerous other genes also showed significant changes in expression in 3T3.mD52 cells (Supplementary Data).
Discussion
To study the effect of mD52 expression on nontransformed cells, contact inhibited murine 3T3 fibroblasts were transfected with the full-length cDNA for mD52. Expression of mD52 was confirmed by RT-PCR and Western blot analysis (Fig. 1) , and the resultant cell line was designated 3T3.mD52. At 4 weeks of culture, 3T3.mD52 cells gained a 2-fold increase in growth rate, lost contact inhibition, and exhibited a marked morphologic change (Fig. 3) . Further characterization revealed an acquired ability for anchorage-independent cell growth for the bulk 3T3.mD52 cell line and independent single cell clones of 3T3.mD52 (Fig. 4) . To determine whether 3T3.mD52 cells were also tumorigenic, naïve, immunocompetent syngeneic mice were inoculated subcutaneously with different doses of 3T3.mD52 cells. Tumors measuring >1 cm 2 were detected 60 days postinoculation with 5 Â 10 6 3T3.mD52, and a 50% subcutaneous tumor incidence could be obtained with as few as 5 Â 10 5 3T3.mD52 cells. Remarkably, when lungs from 3T3.mD52 tumor-bearing mice were analyzed, numerous tumor nodules were observed, with nodules ranging from less than 10 to nodules too numerous to count (inoculation with 1 Â 10 5 and 5 Â 10 6 cells, respectively; Fig. 5D ). Interestingly, independent single cell clones of the bulk 3T3.mD52 cell line showed subcutaneous tumor growth patterns that could be divided into three groups: those that formed progressively growing tumor, those that spontaneously regressed over time, and those that failed to grow (Fig. 6A-C, respectively) . These data suggest that the bulk 3T3.mD52 cell line comprised clones that are aggressively tumorigenic, less tumorigenic, and nontumorigenic. This differed somewhat from what was expected given that all single cell clones of 3T3.mD52 were capable of anchorage-independent growth (Fig. 4C) . In addition, single cell clones of 3T3.mD52 capable of forming progressively growing subcutaneous tumors (Fig. 6A ) also formed spontaneous lung metastases (data not shown). Taken together, the data on single cell clones show that the transformed and tumorigenic phenotype was not likely due to a spontaneous event because none of the single cell clones of the vector-transfected cell line 3T3.V were capable of anchorage-independent growth (Fig.  4C ) or subcutaneous growth in vivo (Fig. 6D) . Further support for the metastatic capacity of 3T3.mD52 cells was the demonstration that TGF-h1 secretion increased in 3T3.mD52 cells compared with 3T3 controls (Fig. 7) . Finally, cDNA microarray analysis showed a gene expression pattern that further supported mD52-induced transformation and metastasis (Table 1 ; Supplementary Data). Of note, what seemed to be metastases were also observed, by gross visual examination, in the spleens and livers of 3T3.mD52 tumor-bearing mice (data not shown).
Recently, Wang et al. (3) reported the discovery of a novel, prostate-specific, and androgen-responsive TPD52 isoform PrLZ, which was shown to be amplified on chromosome 8q21.1 in human prostate cancer. PrLZ was overexpressed in prostate cancer cell lines regardless of androgen receptor status. Similar to TPD52 and 8q amplification in breast cancer (19) , PrLZ is the first and possibly only prostate-specific gene associated with 8q amplification in prostate cancer identified to date and may play a role in malignant transformation of normal prostate epithelial cells. A fourth TPD52-like gene (TPD52L3, hD55) was recently identified in human testis using cDNA microarray (7). hD55 contains a coiled-coil motif and was shown to interact with hD52, hD53, hD54, and itself (hD55) in pull-down assays and was determined to be expressed 5.6-fold higher in adult testis compared with fetal testis, suggesting a role for hD55 in testis development and spermatogenesis. Previously, expression of hD52 (termed PC-1) in murine NIH3T3 cells [American Type Culture Collection (ATCC; Manassas, VA) CRL-1658] produced increased growth rate, the ability to grow in soft agar, and the ability to form subcutaneous tumors in immune-deficient nude mice (36) . In the present study, our data showed the formation of subcutaneous tumors in immunocompetent mice and the gain of metastatic ability in the independent 3T3 cell line (ATCC CCL 92) following the expression of mD52, the murine orthologue of hD52. It has been proposed that cancer is the result of a succession of genetic changes that lead to the transformation of normal cells into malignant cells, and that this progression to malignancy involves six essential alterations: self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, evasion of apoptosis, limitless replicative potential, angiogenesis, and tissue invasion and metastasis (37) . Others have suggested that the steps in progression to metastasis include additional gained functions of the malignant cell to include embolization, survival in the circulation, arrest, extravasation, evasion of host defenses, and progressive growth at distant sites in the host (37) . Regardless of the initiating events and the amount of time needed to progress to metastasis, it is becoming clear that there are genes in which expression seems critical for the generation of a metastatic cell, and that these genes fit into the previously proposed essential alterations and steps toward metastasis (37, 38) . Among these genes are those that are up-regulated in 3T3.mD52 cells, including Vav3 (29), the antiapoptosis gene CARD10 (39), and integrin-a3 and integrin-a6, two members of the integrin family involved in the inhibition of apoptosis, growth stimulation, adhesion, and metastasis (30) (31) (32) . Several genes that may be important in preventing tumor formation and metastasis were downregulated in 3T3.mD52 cells, including caveolin (34), four members of the cadherin gene family (40) , specifically cadherins 11 and 2 and protocadherins 7 and 18, as well as the antiangiogenesis gene thrombospondin 2 (35) . The candidate tumor suppressor Plagl1 (41, 42) was also downregulated in 3T3.mD52 cells.
In addition to these and other genes (Supplementary Data) that were differentially expressed in 3T3.mD52 cells, we measured an increase in TGF-h1 expression and secretion and a decrease in expression of its receptor (TGF-hR1/ALK-5). Malignant cells often secrete elevated amounts of TGF-h1, which aid in increased invasion and metastasis. It is clear that TGF-h1 can act as both a transformation inhibitor for benign cells and as a progressive factor for malignant transformation, invasion, and metastasis (43) (44) (45) . In addition, TGF-h1 has shown roles in each of the aforementioned six essential alterations that make up the hallmarks of cancer (37) microenvironment has been shown to activate proteases that enable the degradation of the extracellular matrix, enabling invasion and subsequent metastasis (reviewed in refs. 27, 28) . Concomitant with increased secretion of TGF-h1 by cancer cells is an observed decrease in expression of receptors for TGF-h1 such as TGF-hR1, which has been shown to lead to increased cancer risk, tumorigenicity, and metastasis in several human cancers to include cancers of the kidney and bladder (47) , colon (48) , pancreas (49) and prostate (50) . The decrease or loss of expression of a TGF-hR is often through mutations that alter its signaling functions (43) . The present study suggests that mD52 is capable of initiating cellular transformation, tumorigenesis, and progression to metastasis, and that 3T3.mD52 cells may represent a model to study TPD52 involvement in tumorigenesis and metastasis. Furthermore, the ability of a single gene to produce changes in cell function and behavior supports the importance of TPD52 and its role in cancer.
Materials and Methods
Subcloning of mD52 cDNA for Eukaryotic Expression
Previously, the full-length cDNA encoding mD52 (1) was cloned into the pTL1 vector and termed pTL1mD52. For eukaryotic expression studies, mD52 cDNA was first subcloned from pTL1mD52 into pMT/V5-His (Invitrogen Corp., Carlsbad, CA). Next, pMT/V5-His was digested, and the mD52 cDNA fragment was ligated into the EcoRV and XhoI site of pcDNA3.1(+) (Invitrogen). The pcDNA.mD52 clone was confirmed by digesting minipreps with BamHI and XhoI (Promega Corp., Madison, WI) and by DNA sequencing (Texas Tech University Molecular Biology core).
Mice and Cell Lines
Female, 6-to 8-week-old BALB/c mice were purchased from the NIH (Frederick, MD). All animals were cared for and treated according to institutional guidelines. Cells were cultured in RPMI 1640 (Fisher Scientific, Pittsburgh, PA) supplemented with 10% heat-inactivated fetal bovine serum, 2 mmol/L Lglutamine, 250 ng/mL Fungizone, 50 IU/mL penicillin, 50 Ag/mL streptomycin, 50 Ag/mL gentamicin sulfate, and 10 mmol/L HEPES. The 3T3.mD52 and 3T3.V (vector control) cell lines were generated by transfecting parent 3T3 fibroblasts (Swiss albino 3T3 cells that were not immortalized or virally transduced and known to be contact inhibited ATCC CCL 92; ref. 51) with pCDNA3.1 containing the full-length cDNA for mD52 (pcDNA.mD52) or empty pCDNA3.1(+), respectively, using LipofectAMINE Plus reagent (Invitrogen) and methods previously described (25) . Forty-eight hours following transfection, 3T3.V and 3T3.mD52 were selected and subsequently maintained in 1 mg/mL G418.
RNA Isolation and RT-PCR Analysis
Total RNA was isolated from 3T3 (negative control), 3T3.V (vector alone), and 3T3.mD52 (mD52 cDNA transfected) cell lines using the TRIzol reagent (Bio Whittaker, Walkersville, MD), and 1 Ag was reverse transcribed to obtain cDNA. mD52 amplification reactions were carried out using the following primers: mD52 forward: 5 ¶-TGCTGAAGACAGAGCCGG-3 ¶; and mD52 reverse: 5 ¶-ACGTCTTGCCACCCTTTG-3 ¶; and previously described PCR conditions for 30 cycles and an annealing temperature of 62jC (26) . RT-PCR for the detection of TGF-b1 and TGF-bR1/ALK-5 (receptor) was carried out using cDNA generated as described above with commercially available primers and the manufacturer's recommended annealing temperature (55jC) and cycle number (ref. 36 ; R&D Systems, Inc., Minneapolis, MN). All PCR reactions were carried out in 50 AL, and the results were visualized on 2% agarose gels containing ethidium bromide. Amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using an annealing temperature of 60jC and 25 cycles served as an internal reference control.
Real-time RT-PCR Analysis
Real-time PCR was done using cDNA samples generated as described above and the ABI Prism 7000 Sequence Detection System and ABI SYBR green PCR core reagents kit according to the manufacturer's instructions (Applied Biosystems, Foster City, CA). PCR conditions for 40 cycles were 50jC for 2 min, 95jC for 10 min, 95jC for 15 s, and an annealing temperature of 62jC for 1 min for mD52 primers (60jC annealing temperature was used for GAPDH control reactions). Additional controls were no template and no enzyme and were included in all real-time PCR reactions.
Western Blot Analysis
The cell lines 3T3.V, 3T3.mD52 were grown to confluency in RPMI supplemented as described above. Cells were harvested and counted, and whole cell protein lysates were prepared at a concentration of 1 Â 10 8 cell equivalents/mL using methods previously described (25) . Briefly, 10 AL of lysate were loaded onto a standard SDS-PAGE (4% stacking, 12% resolving) and run at 200 V for 15 min and 150 V for 40 min, followed by electrolytic transfer onto nitrocellulose. The nitrocellulose membrane was blocked for 1 to 2 h at room temperature in 0.0067 mol/L phosphate-buffered NaCl solution/0.02% Tween containing 1% normal goat serum and 1% evaporated milk. To visualize the expression of mD52 protein, the membrane was probed overnight at 4jC with 25 Ag/mL of anti-TPD52 polyclonal antibody [generated by immunizing rabbits with NH 2 -terminal, carrier-conjugated peptide GCAYKKTSETLSQAGQKAS (italics represents a region of the TPD52 protein that is conserved between human and mouse; Bio Synthesis, Inc., Lewisville, TX). The membrane was simultaneously probed with a 1:500 dilution of polyclonal goat anti-actin antibody (clone I-19, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) to serve as a control reference for protein loading. Following three washes with 0.0067 mol/L phosphate-buffered NaCl solution/0.02% Tween, goat anti-rabbit IgG and rabbit anti-goat IgG horseradish peroxidase -conjugated secondary antibodies were added at 1:1,000 dilutions for 2 h at room temperature. Finally, the membrane was washed and developed with 3,3 ¶-diaminobenzidine reagent as a substrate (Sigma, St. Louis, MO).
Cell Proliferation Assay
Confluent cultures of 3T3, 3T3.V, and 3T3.mD52 cells were harvested and plated in 96-well flat-bottomed plates, in triplicate at 5 Â 10 3 cells per well. Cell proliferation was measured at 24-, 48-, and 72-h intervals using Cell Titer 96 Non-Radioactive Cell Proliferation Assay (MTT based; Promega) according to the manufacturer's instructions. Briefly, cells were incubated at 37jC and 5% CO 2 , then 15 AL of the dye solution was added to each well at the above time intervals. Next, 100 AL of stop solution was added to each well, and the plates were incubated at room temperature for 1 h. Finally, absorbance at 570 nm was measured on a Victor3 automated plate reader (Wallac, Perkin-Elmer, Boston, MA).
Single Cell Cloning of Transfected 3T3 Cell Lines
Clonal populations of 3T3 cells transfected with either pCDNA3.1 empty vector (3T3.V) or pCDNA3.1.mD52 (3T3.mD52) were generated to assess transformation in vitro and tumorigenicity in vivo compared with the bulk parental cell lines using previously published methods (51) . Briefly, confluent cultures of the parental 3T3.V and 3T3.mD52 were harvested with trypsin, washed, and counted. Cells were serially diluted to a concentration of 4 to 5 cells/mL in medium and dispensed into five individual 96-well flat-bottomed microculture plates at 200 AL/well. Confluent wells originating from dilutions of <1 cell per well were expanded to 24-well plates and then to T25 tissue culture flasks to ensure enough cells for in vitro experiments, in vivo inoculation, and cryopreservation.
Assay for Anchorage-Independent Cell Growth
Anchorage-independent growth was determined using a modification of previously described methods (52) . Briefly, a base layer of 0.6% agar in complete medium was plated in six-well plates and allowed to solidify (1 mg/mL G418 was added to wells containing 3T3.V, 3T3.mD52 or single cell clones from both 3T3.V and 3T3.mD52). Next, duplicate wells were overlaid with 5 Â 10 4 cells per well in a 0.3% agar. A growth control well was included with 5 Â 10 4 cells in medium alone (no agar) for each cell line. The plates were incubated at 37jC, 5% CO 2 for 10 to 15 days and checked every 2 to 3 days for colony formation. At day 15, individual colonies (defined as clusters of 15 or more cells) were counted in 10 random fields. 
In vivo Tumor Growth
Evaluation of Spontaneous Lung Metastases
To analyze tumor metastasis to the lungs, mice were sacrificed, and their lungs removed and injected with India ink to visualize individual tumor nodules as described previously (25) . Briefly, an India ink solution was injected through the trachea and allowed to fill the lungs. The lungs were removed and placed in Fekete's solution (70% ethanol, 10% formaldehyde, 5% acetic acid) for destaining. Tumor nodules do not absorb India ink, which results in the normal lung tissue staining black and the tumor nodules remaining white.
ELISA for TGF-b1 Production
To analyze the comparative secretion of TGF-h1, 3T3, 3T3.V, and 3T3.mD52 cell lines were plated in duplicate in 12-well plates at 5 Â 10 5 cells per well. Cells were grown to confluency (f72 h) in complete medium, then washed and incubated for 24 h in medium without serum. After the final incubation, cell supernatants were collected, and like wells were pooled for analysis of TGF-h1 protein secretion by antigen capture ELISA. TGF-h1 was measured and quantified for duplicate determinations using a Quantikine Mouse/Rat/Porcine TGF-h1 Immunoassay kit (R&D Systems), and absorbance at 450 nm was measured on a Victor3 automated plate reader (Wallac, Perkin-Elmer).
Microarray Analysis of Differential Gene Expression in 3T3.mD52 Cells
Quality RNA samples obtained from 3T3 and 3T3.mD52 cells were analyzed using GeneChip Mouse Genome 430 2.0 arrays containing over 39,000 transcripts (Affymetrix). Doublestranded cDNA and biotinylated complementary RNA (cRNA) were synthesized from total RNA and hybridized onto microarrays. The array hybridization, washing, and staining procedures were done according to the manufacturer's protocols. All data used were derived from Affymetrix 5.0 software. GeneChip output files were given as a signal that represents the difference between the intensities of the sequence-specific perfect match probe set and the mismatch probe set or as detection of present, marginal, or absent signals as determined by the program's algorithm. Gene arrays were scaled to an average signal of 1,500 and then analyzed independently. After raw image DAT data files were initially processed to create CEL files, DNA-Chip analyzer (dCHIP; Version 1.3) 6 was used for data quality checking and high-level analysis. A foldchange analysis was done in which the ratio of the geometric means of the expression intensities of the relevant gene fragments was computed. This ratio was reported as the fold change (up or down). Only genes with differences between 3T3.mD52 and 3T3 control greater than 2.0-fold (90% lower bound) were considered to be differentially expressed in 3T3.mD52 cells.
Statistical Analysis
For microarray analyses, confidence intervals and P values on the fold change were calculated with the use of a two-sided, Welch-modified two-sample t test. P values of 0.01 or less were considered significant. For proliferation and TGF-h1 secretion, one-way ANOVA and Tukey-Kramer multiple comparison tests were done. For ANOVA, P values <0.05 were considered significant. For Tukey-Kramer, if q > 5.910, then P < 0.05 and is considered significant (GraphPad InStat).
